Beatriz Grinsztejn, MD, PHD

BEATRIZ GRINSZTEJN, MD, PHD

International AIDS Society (IAS) President, FIOCRUZ STI/AIDS Prevention and Therapeutic Clinical Trials Unit, Rio de Janeiro, Brazil

Dr. Grinsztejn is an Infectious Diseases physician-scientist dedicated to HIV prevention and care for over 30 years. She is the Director of the FIOCRUZ STI/AIDS Prevention and Therapeutic Clinical Trials Unit, which develops and implements prevention and therapeutic clinical trials and cohort studies. The unit is affiliated with the HIV Prevention Trials Network (HPTN), the Advancing Clinical Therapeutics Globally for HIV/AIDS and Other Infections (ACTG), the HIV Vaccine Trials Group (HVTN), the COVID-19 Prevention Network (CoVPN), and the ANRS.

“My focus is on conducting research and generating evidence to inform and empower communities, shedding light on the health disparities that heavily impact the most vulnerable populations. Navigating the scientific landscape as a woman in a region where machismo prevails has been a persistent challenge. Also, being a lesbian compounded the challenges associated with LGBTQIAPN+phobia in my professional environment. As a female scientist, beyond serving as an empowering example for future generations, I actively engage in mentoring young women investigators aiming at inspiring them to pursue careers in science.”